Arya Pharma (Pty) Ltd

Arya Pharma (Pty) Ltd is a commercial entity whose name follows the South African private-company convention: "(Pty) Ltd" is the abbreviation for a proprietary limited company under South African company law, indicating a privately held corporate form rather than a listed or state-owned entity. The name combines "Arya Pharma" — a pharmaceutical-sounding trade name — with that South African legal suffix, which is the strongest identity signal available for this subject. The evidence supplied with this record does not contain any material about Arya Pharma (Pty) Ltd itself. The two snippets are Chinese-language news articles: one concerns "丰菽" 2.0, a soybean-focused agricultural large language model released by Anhui Agricultural University and the Chinese Academy of Agricultural Sciences, and the other is a commentary on Chinese e-commerce livestreaming, Tmall Double 11 sales and brand profitability. Neither mentions Arya Pharma, South African pharmaceuticals, or any related company, product, executive or transaction. They therefore cannot be used to support claims about this brand. Because of this, the dossier deliberately stays minimal. No founding year, founder, headquarters city, website, ownership structure, product portfolio, executive team or market footprint can be stated without inventing facts. What can reasonably be inferred is only the legal-form signal in the name and the general sector implied by "Pharma" — that is, a company positioned in pharmaceuticals or healthcare products. Whether Arya Pharma (Pty) Ltd is an active manufacturer, a distributor, a wholesaler, a licence holder or a dormant shell cannot be determined from the available evidence. Readers should treat this entry as an identity stub pending verification from primary sources such as the South African Companies and Intellectual Property Commission (CIPC) register, the company's own website or regulatory filings with the South African Health Products Regulatory Authority (SAHPRA). Once such sources are available, the entry should be expanded with founding details, ownership, licensed products and market positioning.

No verifiable history of Arya Pharma (Pty) Ltd could be established from the supplied evidence. The two source snippets are unrelated Chinese-language articles — one on the soybean agricultural model "丰菽" 2.0 launched by Anhui Agricultural University and the Chinese Academy of Agricultural Sciences, and one on Chinese livestream commerce and Tmall Double 11 brand economics — and neither references Arya Pharma, its founders, its incorporation, its products or its markets. The only historically stable fact is the legal form embedded in the name: the "(Pty) Ltd" suffix indicates registration as a private proprietary limited company under South African company law. This tells us the entity is a privately held company rather than a public listed company, but it does not establish when it was incorporated, by whom, or whether it remains active. Any narrative of founding, growth, product launches, ownership changes or market expansion would be speculation and is therefore omitted. A proper history should be reconstructed from primary records: the CIPC company register for incorporation date, directors and shareholding; SAHPRA licensing records for medicines or medical devices; and the company's own corporate communications. Until such sources are located, this section remains intentionally empty of dated events.

• 2026

  Sahpra orders recall of four batches of Enalapril 10mg Arya

  The South African Health Products Regulatory Authority (Sahpra) ordered the recall of four batches of Enalapril 10mg Arya, a hypertension medicine, after post-marketing inspections flagged out-of-specification results. The recall is classified as Class II-Type A and is being implemented by Arya Pharma (Pty) Ltd in consultation with Sahpra. Patients, healthcare professionals, pharmacies, wholesalers and other suppliers are urged to check stock and stop dispensing the affected batches.

  Source

Read more

• Unconfirmed

  Sahpra orders recall of four batches of Enalapril 10mg Arya[3]Sahpra orders recall of four batches of Enalapril 10mg Aryacitizen.co.za

  Reported: 2026-08-17

  The South African Health Products Regulatory Authority (Sahpra) ordered the recall of four batches of Enalapril 10mg Arya, a hypertension medicine, after post-marketing inspections flagged out-of-specification results. The Class II-Type A recall is being implemented by Arya Pharma (Pty) Ltd in consultation with Sahpra, and patients, healthcare professionals, pharmacies, wholesalers and other suppliers are urged to check stock and stop dispensing affected batches.

1. 1我国科学家发布大豆垂直大模型“丰菽”2.0，推动实现辅助育种_网易订阅163.com
2. 2直播退烧，品牌迎来梦醒时分|天猫|电商|退货率|三只松鼠|集团总收入_网易订阅163.com
3. 3Sahpra orders recall of four batches of Enalapril 10mg Aryacitizen.co.za